| COPN Stock | | | CHF 64.60 0.40 0.62% |
Insider
Marco Lecchi is Chief Officer of COSMO Pharmaceuticals SA
| Age | 59 |
| Phone | 353 1 817 0370 |
| Web | https://www.cosmopharma.com |
COSMO Pharmaceuticals Management Efficiency
The company has return on total asset
(ROA) of
0.0181 % which means that it generated a profit of $0.0181 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0841 %, meaning that it generated $0.0841 on every $100 dollars invested by stockholders. COSMO Pharmaceuticals' management efficiency ratios could be used to measure how well COSMO Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.
COSMO Pharmaceuticals SA has accumulated 169.03
M in total debt with debt to equity ratio
(D/E) of 35.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. COSMO Pharmaceuticals has a current ratio of 23.89, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist COSMO Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, COSMO Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like COSMO Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for COSMO to invest in growth at high rates of return. When we think about COSMO Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, develops, manufactures, and distributes products for gastroenterology and endoscopy worldwide. Cosmo Pharmaceuticals N.V. was founded in 1997 and is headquartered in Dublin, Ireland. COSMO PHARM operates under Drug Manufacturers - Major classification in Switzerland and is traded on Switzerland Exchange. It employs 306 people. COSMO Pharmaceuticals SA (COPN) is traded on SIX Swiss Exchange in Switzerland and employs 292 people.
Management Performance
COSMO Pharmaceuticals Leadership Team
Elected by the shareholders, the COSMO Pharmaceuticals' board of directors comprises two types of representatives: COSMO Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of COSMO. The board's role is to monitor COSMO Pharmaceuticals' management team and ensure that shareholders' interests are well served. COSMO Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, COSMO Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Niall Donnelly, Chief Officer | |
| Biagio Vigano, Chief Officer | |
| Davide Malavasi, Qualified Director | |
| Marco Lecchi, Chief Officer | |
| Luigi Longo, Chief Officer | |
| Hazel Winchester, Head Relations | |
| Giulio Evangelisti, AI Production | |
| Alessandro LLM, CEO Director | |
| Ngo Nhan, Head IT | |
| Mauro Ajani, Founder Chairman | |
COSMO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is COSMO Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for COSMO Stock Analysis
When running COSMO Pharmaceuticals' price analysis, check to
measure COSMO Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSMO Pharmaceuticals is operating at the current time. Most of COSMO Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of COSMO Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSMO Pharmaceuticals' price. Additionally, you may evaluate how the addition of COSMO Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.